TWM647363U - Capsule soluble structure in intestine capable of resisting stomach acidity - Google Patents
Capsule soluble structure in intestine capable of resisting stomach acidity Download PDFInfo
- Publication number
- TWM647363U TWM647363U TW111211025U TW111211025U TWM647363U TW M647363 U TWM647363 U TW M647363U TW 111211025 U TW111211025 U TW 111211025U TW 111211025 U TW111211025 U TW 111211025U TW M647363 U TWM647363 U TW M647363U
- Authority
- TW
- Taiwan
- Prior art keywords
- capsule
- gastric acid
- resistant
- enteric
- combination
- Prior art date
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 83
- 210000000936 intestine Anatomy 0.000 title abstract description 5
- 210000002784 stomach Anatomy 0.000 title description 2
- 210000004211 gastric acid Anatomy 0.000 claims abstract description 28
- 239000007788 liquid Substances 0.000 claims abstract description 6
- 239000002195 soluble material Substances 0.000 claims abstract description 6
- 239000000463 material Substances 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims abstract description 5
- 239000002253 acid Substances 0.000 claims description 3
- 230000000968 intestinal effect Effects 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 abstract description 7
- 108090000790 Enzymes Proteins 0.000 abstract description 7
- 239000004480 active ingredient Substances 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 5
- 239000006041 probiotic Substances 0.000 abstract description 5
- 235000018291 probiotics Nutrition 0.000 abstract description 5
- 238000004090 dissolution Methods 0.000 abstract description 4
- 230000031891 intestinal absorption Effects 0.000 abstract description 4
- 239000003921 oil Substances 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 3
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 239000003292 glue Substances 0.000 abstract 1
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 210000003238 esophagus Anatomy 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000006067 antibiotic powder Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
一種膠囊之抗胃酸的腸溶結構，係包含一膠囊、一帶體，該膠囊由一膠 囊殼與一膠囊套組合而成，並於該膠囊內容裝液體成分，該膠囊殼與該膠囊套選自抗胃酸、腸溶性材料，該帶體選自抗胃酸、腸溶性材料，該帶體繞設於該膠囊殼與該膠囊套組合處，並將該組合處緊密包覆。應用抗胃酸、腸溶性材料其酸鹼敏感特性，保護有效成分不被胃酸破壞，可限定膠囊在腸道快速溶解，可發揮腸道充分吸收的最大功效，非常適合益生菌、油性，酵素、酶類等配方的產品，且低含水量，適合潮濕性粉末；再者應用帶體將該膠囊殼與該膠囊套組合處緊密包覆，可以防止膠囊在胃酸中快速分解、蹦開，因為緊密包覆所以防潮性佳，可以保持原料的活性及安定性。 A gastric acid-resistant enteric-coated structure of a capsule includes a capsule and a body, and the capsule is composed of a glue The capsule shell is combined with a capsule sleeve, and a liquid component is filled in the capsule. The capsule shell and the capsule sleeve are selected from gastric acid-resistant and enteric-coated materials. The belt body is selected from gastric acid-resistant and enteric-coated materials. It is wound around the combination of the capsule shell and the capsule sleeve, and tightly covers the combination. The use of gastric acid-resistant and enteric-soluble materials with their acid-base sensitive properties protects the active ingredients from being destroyed by gastric acid. It can limit the rapid dissolution of the capsule in the intestines and maximize intestinal absorption. It is very suitable for probiotics, oils, enzymes, and enzymes. products with similar formulas and low water content, suitable for moist powder; in addition, a belt should be used to tightly cover the combination of the capsule shell and the capsule cover, which can prevent the capsule from quickly decomposing and popping open in the gastric acid, because the tight packaging The coating has good moisture resistance and can maintain the activity and stability of the raw materials.
Description
本創作係有關於一種膠囊技術領域，特別是指其為一種膠囊之抗胃酸的腸溶結構。 The invention relates to the technical field of capsules, in particular to a gastric acid-resistant enteric-coated structure of the capsule.
按；以前通常遇到要服藥時才會服用膠囊，但是現在許多保健品，像是維生素B群、魚油、益生菌等也常常會使用到膠囊型，膠囊目的功能是包裹膠囊內的成份的苦澀味與臭味，讓粉狀成分不易進入呼吸道而嗆到，而膠囊的多種顏色可方便辦識、可阻隔氧氣與光線，提高成分的穩定性。 Press; In the past, capsules were usually taken when taking medicine, but now many health products, such as vitamin B complex, fish oil, probiotics, etc., often use capsule type. The purpose of the capsule is to wrap the bitterness of the ingredients in the capsule. The taste and odor prevent the powdery ingredients from easily entering the respiratory tract and causing choking. The various colors of the capsules make it easier to read, block oxygen and light, and improve the stability of the ingredients.
有些藥物膠囊不能，是因為目的在於遮擋藥味、保護食道與胃黏膜，例如抗生素類的藥粉具有腐蝕性，打開易灼傷食道。 Some medicine capsules cannot be used because their purpose is to block the smell of the medicine and protect the esophagus and gastric mucosa. For example, antibiotic powders are corrosive and can easily burn the esophagus when opened.
腸溶性膠囊若提早打開，則會破壞藥性，影響藥效。因此藥物不僅不可打開膠囊，更需遵守飯前、飯後的醫囑服用。 If enteric-coated capsules are opened early, the properties of the medicine will be destroyed and the efficacy of the medicine will be affected. Therefore, not only should the capsules of the drug not be opened, but it must also be taken according to the doctor's instructions before and after meals.
要強調的是，有些益生菌、油性，酵素、酶類等配方的產品，不適合於胃部胃酸環境中先溶解，而比較適合在腸道快速溶解，如此才能保護有效成分不被胃酸破壞，方可發揮腸道充分吸收的最大功效。 It should be emphasized that some products with probiotic, oily, ferment, and enzyme formulas are not suitable for dissolving in the gastric acid environment of the stomach, but are more suitable for rapid dissolution in the intestines, so as to protect the active ingredients from being destroyed by gastric acid. It can maximize intestinal absorption.
目前膠囊種類大致分為動物性膠囊、植物性膠囊，但其缺點分別敘述如下：動物性膠囊：在胃酸環境30分鐘後，接近全溶解，對內容物完全無保護作用。 At present, the types of capsules are roughly divided into animal capsules and plant-based capsules, but their disadvantages are described as follows: Animal-based capsules: nearly completely dissolve after 30 minutes in a gastric acid environment, and have no protective effect on the contents.
植物性膠囊：在胃酸環境120分鐘後，溶出率達55.8%，有效成份已被破壞。 Plant-based capsules: After 120 minutes in a gastric acid environment, the dissolution rate reaches 55.8%, and the active ingredients have been destroyed.
綜合以上所述，目前動物性膠囊、植物性膠囊其抗胃酸之功效極差，如何改善其缺點，為業界一大課題。 Based on the above, current animal-based capsules and plant-based capsules have extremely poor anti-gastric acid effects. How to improve their shortcomings has become a major issue in the industry.
爰是，本創作人乃秉持多年從事產品設計、開發之實務經驗，積極潛心研發思考、改良創新，經由無數次之實際試驗，致有本創作之產生。 Yes, the creator of this product has many years of practical experience in product design and development, and has actively devoted himself to R&D, thinking, improvement and innovation. After countless practical tests, this creation was born.
本創作之目的，係在提供一種膠囊之抗胃酸的腸溶結構。 The purpose of this invention is to provide a capsule with an enteric-coated structure that is resistant to gastric acid.
為達上述之目的，本創作係包含一膠囊、一帶體，其中，該膠囊由一膠囊殼與一膠囊套組合而成，並於該膠囊內容裝液體成分，該膠囊殼與該膠囊套選自抗胃酸、腸溶性材料；該帶體選自抗胃酸、腸溶性材料，該帶體繞設於該膠囊殼與該膠囊套組合處，並將該組合處緊密包覆。 In order to achieve the above purpose, the invention includes a capsule and a belt. The capsule is composed of a capsule shell and a capsule cover, and liquid ingredients are filled in the capsule. The capsule shell and the capsule cover are selected from Gastric acid-resistant and enteric-soluble materials; the belt body is selected from gastric acid-resistant and enteric-soluble materials. The belt body is wound around the combination of the capsule shell and the capsule cover and tightly covers the combination.
應用抗胃酸、腸溶性材料其酸鹼敏感特性，保護有效成分不被胃酸破壞，可限定膠囊在腸道快速溶解，可發揮腸道充分吸收的最大功效，非常適合益生菌、油性，酵素、酶類等配方的產品，且低含水量，適合潮濕性粉末。 The use of gastric acid-resistant and enteric-soluble materials with their acid-base sensitive properties protects the active ingredients from being destroyed by gastric acid. It can limit the rapid dissolution of the capsule in the intestines and maximize intestinal absorption. It is very suitable for probiotics, oils, enzymes, and enzymes. Products with similar formulas and low water content, suitable for moist powders.
再者應用帶體將該膠囊殼與該膠囊套組合處緊密包覆，可以防止膠囊在胃酸中快速分解、蹦開，因為緊密包覆所以防潮性佳，可以保持原料的活性及安定性。 Furthermore, a belt is used to tightly cover the combination of the capsule shell and the capsule cover, which can prevent the capsule from quickly decomposing and popping open in gastric acid. Because of the tight covering, it has good moisture resistance and can maintain the activity and stability of the raw materials.
以下僅藉由具體實施例，且佐以圖式作詳細之說明。 The following is a detailed description only through specific embodiments and drawings.
10:膠囊 10:Capsule
11:膠囊殼 11:Capsule shell
12:膠囊套 12:Capsule set
13:液體成分 13:Liquid ingredients
14:顆粒成分 14:Particle composition
20:帶體 20:With body
第1圖係本創作之立體圖。 Picture 1 is a three-dimensional view of this creation.
第2圖係本創作之立體分解圖。 Picture 2 is a three-dimensional exploded view of this creation.
第3圖係本創作之剖面圖。 Figure 3 is a cross-sectional view of this creation.
請參閱第1圖、第2圖、第3圖所示，本創作係包含一膠囊10、一帶體20。下文將詳細說明之：該膠囊10由一膠囊殼11與一膠囊套12組合而成，並於該膠囊10內容裝液體成分13，該膠囊殼11與該膠囊套12選自抗胃酸、腸溶性材料。
Please refer to Figure 1, Figure 2, and Figure 3. This invention includes a
該帶體20選自抗胃酸、腸溶性材料，該帶體20繞設於該膠囊殼11與該膠囊套12組合處，並將該組合處緊密包覆。
The
於一實施例，該膠囊10內容裝包含有顆粒成分14或者粉末成分。
In one embodiment, the
於一實施例，該膠囊10選自抗酸植物性膠囊。
In one embodiment, the
於一實施例，該帶體20具有顏色者。
In one embodiment, the
上述為本創作之各部構件及其組成方式介紹，接著再將本創作之使用特點、功效介紹如下：本創作應用抗胃酸、腸溶性材料其酸鹼敏感特性，保護有效成分不被胃酸破壞，可限定膠囊10在腸道快速溶解，可發揮腸道充分吸收的最大功效，非常適合益生菌、油性，酵素、酶類等配方的產品，且低含水量，適合潮濕性粉末。
The above is an introduction to each component of this creation and its composition method, and then the usage characteristics and functions of this creation are introduced as follows: This creation uses gastric acid-resistant and enteric-coated materials with acid-base sensitive properties to protect the active ingredients from being destroyed by gastric acid. The
再者應用帶體20將該膠囊殼11與該膠囊套12組合處緊密包覆，可以防止膠囊10在胃酸中快速分解、蹦開，因為緊密包覆所以防潮性佳，可以保持原料的活性及安定性。
Furthermore, the
以上為本案所舉之實施例，僅為便於說明而設，當不能以此限制本案之意義，即大凡依所列申請專利範圍所為之各種變換設計，均應包含在本案之專利範圍中。 The above-mentioned embodiments in this case are only for convenience of explanation and should not be used to limit the significance of this case. That is, all various transformation designs based on the listed patent scope should be included in the patent scope of this case.
10:膠囊 10:Capsule
11:膠囊殼 11:Capsule shell
12:膠囊套 12:Capsule set
13:液體成分 13:Liquid ingredients
14:顆粒成分 14:Particle composition
20:帶體 20:With body
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW111211025U TWM647363U (en) | 2022-10-07 | 2022-10-07 | Capsule soluble structure in intestine capable of resisting stomach acidity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW111211025U TWM647363U (en) | 2022-10-07 | 2022-10-07 | Capsule soluble structure in intestine capable of resisting stomach acidity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TWM647363U true TWM647363U (en) | 2023-10-21 |
Family
ID=89857013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW111211025U TWM647363U (en) | 2022-10-07 | 2022-10-07 | Capsule soluble structure in intestine capable of resisting stomach acidity |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TWM647363U (en) |
-
2022
- 2022-10-07 TW TW111211025U patent/TWM647363U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6836977B2 (en) | Acid-resistant two-piece hard capsule acid-resistant banding solution | |
| CN103282028B (en) | The method of the stable Gelseal of preparation containing microencapsulation probiotic bacteria | |
| CN102665697A (en) | Acid resistant capsules | |
| BRPI1013917A2 (en) | enzyme release systems and methods of preparation and use | |
| EA014825B1 (en) | Method for stabilising pharmaceutical administration forms that contain micro-organisms | |
| TWI584824B (en) | A capsule for delivery to a large intestine and a method of manufacturing the same | |
| RU2466741C2 (en) | Composition and method with using stabilised sensitive ingredient | |
| JPS62201823A (en) | Material containing beneficial enterobacterium and production thereof | |
| TWM647363U (en) | Capsule soluble structure in intestine capable of resisting stomach acidity | |
| TWM597138U (en) | A special intestine-soluble structure for a capsule | |
| CN1887310B (en) | Compound fennel capsule for treating indigestion and its preparationn process | |
| JPH11302158A (en) | Health food having intestinal function controlling action and produced by using enteric seam capsule | |
| JPS6024767B2 (en) | enteric-coated hard capsules | |
| KR102464572B1 (en) | Capsule of probiotics | |
| WO2020238297A1 (en) | Soft capsule containing nadh or nadph, preparation method therefor and application thereof | |
| CN106511294B (en) | A kind of soft capsule and preparation method thereof | |
| CN215022729U (en) | Capsule with three-layer structure | |
| Soares et al. | Study of a delayed-release system for hard and soft capsules coated with eudragit® s100 acrylic polymers | |
| TW201431561A (en) | The enteric capsule with oil coating | |
| JP2008109910A (en) | Enzyme-compounded granule acting in intestine, and enzyme-compounded food using the enzyme-compounded granule | |
| JPH06500553A (en) | Methods and products for eliminating undesirable side effects of eating vegetables such as onions or garlic | |
| Feldman et al. | Cultivate Your Probiotic Performance: Market Trends and Innovative Solutions | |
| TWM620349U (en) | A special moisture-proof structure for a capsules | |
| US20100221332A1 (en) | Methodology and apparatus for oral dual delivery of homeopathic products and non-homeopathic products | |
| TWM630273U (en) | capsule |